Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 29
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol

  • Gutiérrez, Félix|||0000-0002-9485-6867
  • López, Leandro
  • Galera, Carlos
  • Tiraboschi, Juan Manuel|||0000-0002-0073-873X
  • Portu, Joseba
  • García-Fraile Fraile, Lucio|||0000-0002-2512-6107
  • García del Toro, Miguel
  • Bernal, Enrique|||0000-0002-4041-0579
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • García-Abellán, Javier|||0000-0002-5217-3726
  • Flores, Juan
  • González Cordón, Ana|||0000-0002-0894-3711
  • Martínez, Onofre
  • Bravo Urbieta, Joaquín|||0000-0003-2079-0305
  • Rosado, Dácil
  • Montero, Marta|||0000-0002-3432-5394
  • Sirera, Guillem|||0000-0003-4014-9355
  • Torralba, Miguel|||0000-0003-2166-7405
  • Galindo Puerto, María José
  • Macías, Juan|||0000-0002-4778-790X
  • Gónzalez Cuello, Inmaculada|||0000-0001-8519-7823
  • Boix, Vicente|||0000-0002-7015-3948
  • Vivancos, María Jesús
  • Dios Diez, Paula|||0000-0003-2700-6595
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Fernández-González, Marta|||0000-0001-9949-8504
  • Gutiérrez Ortiz de la Tabla, Ana|||0000-0002-6080-0195
  • Martínez, Esteban|||0000-0002-6911-8846
  • Masiá, Mar|||0000-0001-9878-2458
Background. Non-AIDS defining malignancies present a growing challenge for persons with human immunodeficiency virus (HIV, PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was designed to compare two comprehensive cancer screening strategies integrated into routine HIV care. This study reports baseline data on the prevalence and types of precancerous lesions and early-stage cancer among participants at enrolment. Acceptability of the procedure was additionally assessed. Methods. Cross-sectional analysis of a comprehensive screening protocol to detect precancer and cancer. The readiness of healthcare providers to implement the protocol was evaluated using a validated 4-item survey. Results. Among the 1430 enrolled PWH, 1172 underwent 3181 screening tests, with positive findings in 29.4% of cases, leading to further investigation in 20.7%. Adherence to the protocol was 84%, with HIV providers expressing high acceptability (97.1%), appropriateness (91.4%), and feasibility (77.1%). A total of 145 lesions were identified in 109 participants, including 60 precancerous lesions in 35 patients (3.0%), 9 early-stage cancers in 9 patients (0.8%), and 76 low-risk lesions in 65 subjects (5.5%). Adverse events related to screening occurred in 0.8% of participants, all mild. The overall prevalence of cancer precursors or early-stage cancer was 3.8% (95% confidence interval [CI], 2.74%-5.01%), with highest rates observed in individuals screened for anal and colorectal cancers. Conclusions. The baseline comprehensive cancer screening protocol of the IMPAC-Neo study successfully identified a significant proportion of PWH with precancerous lesions and early-stage cancer. High adherence rates and positive feedback from providers suggest effective implementation potential in real-world healthcare settings.
Repisalud
Publication Artículo científico (JournalArticle)

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GRaACE project.

  • Moreno-Grau, Sonia
  • de Rojas, Itziar
  • Hernández, Isabel
  • Quintela, Inés
  • Montrreal, Laura
  • Alegret, Montserrat
  • Hernández-Olasagarre, Begoña
  • Madrid, Laura
  • González-Pérez, Antonio
  • Maroñas, Olalla
  • Rosende-Roca, Maitée
  • Mauleón, Ana
  • Vargas, Liliana
  • Lafuente, Asunción
  • Abdelnour, Carla
  • Rodríguez-Gómez, Octavio
  • Gil, Silvia
  • Santos-Santos, Miguel Ángel
  • Espinosa, Ana
  • Ortega, Gemma
  • Sanabria, Ángela
  • Pérez-Cordón, Alba
  • Cañabate, Pilar
  • Moreno, Mariola
  • Preckler, Silvia
  • Ruiz, Susana
  • Aguilera, Nuria
  • Pineda, Juan Antonio
  • Macías, Juan
  • Alarcón-Martín, Emilio
  • Sotolongo-Grau, Oscar
  • Marquié, Marta
  • Monté-Rubio, Gemma
  • Valero, Sergi
  • Benaque, Alba
  • Clarimón, Jordi
  • Bullido, María Jesús
  • Garcia-Ribas, Guillermo
  • Pástor, Pau
  • Sánchez-Juan, Pascual
  • Álvarez, Victoria
  • Piñol-Ripoll, Gerard
  • García-Alberca, Jose María
  • Royo, José Luis
  • Franco, Emilio
  • Mir, Pablo
  • Calero, Miguel
  • Medina, Miguel
  • Rábano, Alberto
  • Ávila, Jesús
  • Antúnez, Carmen
  • Real, Luis Miguel
  • Orellana, Adelina
  • Carracedo, Ángel
  • Sáez, María Eugenia
  • Tárraga, Lluís
  • Boada, Mercè
  • Ruiz, Agustín
Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta-analyzed with additional genome-wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gated Mesoporous Silica Nanoparticles Using a Double-Role Circular Peptide for the Controlled and Target-Preferential Release of Doxorubicin in CXCR4-Expresing Lymphoma Cells

  • De La Torre, Cristina
  • Casanova, Isolda
  • Acosta, Gerardo
  • Coll Merino, Mª Carmen
  • Moreno, María José
  • Albericio, Fernando
  • Mangues, Ramón
  • Royo, Miriam
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] B-cell non-Hodgkin s lymphoma (B-NHL) is the most frequent malignant lymphoid neoplasm, which has a high degree of relapse and chemoresist-ance. Thus, strategies to improve currently used therapies are needed. In this context, a new CXCR4-targeted delivery system is described using mesoporous silica nanoparticles (MSNs) that are loaded with doxorubicin and capped with a derivative of the T22 peptide ( P ). This design makes full use of the great affi nity of the T22 peptide to CXCR4 receptor, which is overexpressed in lymphoma cells. The peptide is able to guide the gated nanoparticle to B-NHL cells to facilitate MSNs uptake via the CXCR4 receptor. The endocyted P -capped MSNs are also opened by endosomal proteolytic enzymes to allow intracellular doxorubicin delivery., Financial support from the Spanish Government (MAT2012-38429-C04 and PIB2010BZ-00563), Generalitat Valenciana (PROMETEOII/2014/047), Generalitat de Catalunya (2009-SGR-1437), Instituto de Salud Carlos III (FI10/00758 and FIS PII2/01861), MaratoTV3 416/C/2013-2030, CIBER-BBN (Nanomets), and Institut de Recerca Josep Carreras Sant Pau is gratefully acknowledged. C.T. is grateful to the Spanish MEC for her grant. The authors also acknowledge Cristina Suarez for her technical support and the use of the CIBER-BBN Nanotoxicology and Synthesis of Peptides platforms.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

  • García-González, Pablo
  • Rojas, Itziar de
  • Moreno-Grau, Sonia
  • Montrreal, Laura
  • Puerta, Raquel
  • Alarcón-Martín, Emilio
  • Quintela, Inés
  • Orellana, Adela
  • Andrade, Victor
  • Martino-Adami, Pamela V.
  • Heilmann-Heimbach, Stefanie
  • Gómez-Garre, Pilar
  • Periñán, María Teresa
  • Álvarez, Ignacio
  • Díez-Fairen, Mónica
  • Nuñez-Llaves, Raul
  • Olivé-Roig, Claudia
  • García-Ribas, Guillermo
  • Menéndez-González, Manuel
  • Martínez, Carmen
  • Aguilar Barberá, Miquel
  • Buongiorno, Maria Teresa
  • Franco-Macías, Emilio
  • Sáez, María Eugenia
  • Cano, Amanda
  • Bullido, María Jesús
  • Real, Luis Miguel
  • Rodríguez-Rodríguez, Eloy
  • Royo, José Luis
  • Álvarez, Victoria
  • Pastor, Pau
  • Piñol-Ripoll, Gerard
  • Mir, Pablo
  • Calero, Miguel
  • Medina-Padilla, Miguel
  • Sánchez-Juan, Pascual
  • Carracedo, Ángel
  • Valero, Sergi
  • Hernández, Isabel
  • Tárraga, Lluís
  • Ramírez, Alfredo
  • Boada, Mercè
  • Ruiz, Agustín
Mosaic loss of chromosome Y (mLOY) is a common ageing-related somatic event and has been previously associated with Alzheimer’s disease (AD). However, mLOY estimation from genotype microarray data only reflects the mLOY degree of subjects at the moment of DNA sampling. Therefore, mLOY phenotype associations with AD can be severely age-confounded in the context of genome-wide association studies. Here, we applied Mendelian randomisation to construct an age-independent mLOY polygenic risk score (mloy-PRS) using 114 autosomal variants. The mloy-PRS instrument was associated with an 80% increase in mLOY risk per standard deviation unit (p = 4.22 × 10−20) and was orthogonal with age. We found that a higher genetic risk for mLOY was associated with faster progression to AD in men with mild cognitive impairment (hazard ratio (HR) = 1.23, p = 0.01). Importantly, mloy-PRS had no effect on AD conversion or risk in the female group, suggesting that these associations are caused by the inherent loss of the Y chromosome. Additionally, the blood mLOY phenotype in men was associated with increased cerebrospinal fluid levels of total tau and phosphorylated tau181 in subjects with mild cognitive impairment and dementia. Our results strongly suggest that mLOY is involved in AD pathogenesis., P.G.-G. (Pablo García-González) is supported by CIBERNED employment plan CNV-304-PRF-866. CIBERNED is integrated into ISCIII (Instituto de Salud Carlos III). I.d.R is supported by a national grant from the Instituto de Salud Carlos III FI20/00215. A.C. (Amanda Cano) acknowledges the support of the Spanish Ministry of Science, Innovation, and Universities under the grant Juan de la Cierva (FJC2018-036012-I). M.B. (Mercé Boada) and A.R. (Agustín Ruiz) are also supported by national grants PI13/02434, PI16/01861, PI17/01474, PI19/01240, and PI19/01301. The Genome Research @ Fundació ACE project (GR@ACE) is supported by Grifols SA, Fundación bancaria “La Caixa”, Fundació ACE, and CIBERNED. Acción Estratégica en Salud is integrated into the Spanish National R + D + I Plan and funded by ISCIII (Instituto de Salud Carlos III)—Subdirección General de Evaluación—and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de hacer Europa”). Genotyping of the ACE MCI-EADB samples was performed in the context of EADB (European Alzheimer DNA biobank) funded by the JPco-fuND FP-829-029 (ZonMW project number 733051061). This work was supported by a grant (European Alzheimer DNA BioBank, EADB) from the EU Joint Program—Neurodegenerative Disease Research (JPND)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Connecting genomic and proteomic signatures of amyloid burden in the brain

  • Puerta, Raquel
  • de Rojas, Itziar
  • García-González, Pablo
  • Olivé-Roig, Claudia
  • Sotolongo-Grau, Oscar
  • García-Sánchez, Ainhoa
  • García-Gutiérrez, Fernando
  • Montrreal, Laura
  • Tartari, Juan Pablo
  • Sanabria, Ángela
  • Pytel, Vanesa
  • Lage, Carmen
  • Quintela, Ines
  • Aguilera, Nuria
  • Rodríguez-Rodríguez, Eloy
  • Alarcón-Martín, Emilio
  • Orellana, Adelina
  • Pastor, Pau
  • Pérez-Tur, Jordi
  • Pinol-Ripoll, Gerard
  • López de Munain, Adolfo
  • García-Alberca, José María
  • Royo, José Luis
  • Bullido, María Jesús
  • Álvarez, Victoria
  • Real, Luis Miguel
  • Corbatón Anchuelo, Arturo
  • Gómez-Garre, Dulcenombre
  • Martínez Larrad, María Teresa
  • Franco-Macias, Emilio
  • Mir, Pablo
  • Medina, Miguel
  • Sánchez-Valle, Raquel
  • Icardo, Oriol
  • Dols-Sáez, María Eugenia
  • Carracedo, Ángel
  • Tárraga, Lluís
  • Alegret, Montse
  • Valero, Sergi
  • Marquie, Marta
  • Boada, Mercè
  • Juan, Pascual
  • Sánchez Cavazos, José Enrique
  • Cabrera, Alfredo
  • Cano, Amanda
  • Ruiz, Agustín
preprint 42 páginas, 6 figuras, 2 tablas, Background: Alzheimer's disease (AD) has a high heritable component characteristic of complex diseases, yet many of the genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid endophenotypes measured in cerebrospinal fluid (CSF) and positron emission tomography (PET) as surrogates of amyloid pathology, which may be helpful to understand the underlying biology of the disease. Methods: We performed a meta-analysis of GWAS of CSF Aβ42 and PET measures combining six independent cohorts (n=2,076). Due to the opposite effect direction of Aβ phenotypes in CSF and PET measures, only genetic signals in the opposite direction were considered for analysis (n=376,599). Polygenic risk scores (PRS) were calculated and evaluated for AD status and amyloid endophenotypes. We then searched the CSF proteome signature of brain amyloidosis using SOMAscan proteomic data (Ace cohort, n=1,008) and connected it with GWAS results of loci modulating amyloidosis. Finally, we compared our results with a large meta-analysis using publicly available datasets in CSF (n=13,409) and PET (n=13,116). This combined approach enabled the identification of overlapping genes and proteins associated with amyloid burden and the assessment of their biological significance using enrichment analyses. Results: After filtering the meta-GWAS, we observed genome-wide significance in the rs429358-APOE locus and nine suggestive hits were annotated. We replicated the APOE loci using the large CSF-PET meta-GWAS and identified multiple AD-associated genes as well as the novel GADL1 locus. Additionally, we found a significant association between the AD PRS and amyloid levels, whereas no significant association was found between any Aβ PRS with AD risk. CSF SOMAscan analysis identified 1,387 FDR-significant proteins associated with CSF Aβ42 levels. The overlap among GWAS loci and proteins associated with amyloid burden was very poor (n=35). The enrichment analysis of overlapping hits strongly suggested several signalling pathways connecting amyloidosis with the anchored component of the plasma membrane, synapse physiology and mental disorders that were replicated in the large CSF-PET meta-analysis. Conclusions: The strategy of combining CSF and PET amyloid endophenotypes GWAS with CSF proteome analyses might be effective for identifying signals associated with the AD pathological process and elucidate causative molecular mechanisms behind the amyloid mobilization in AD., The Genome Research @ Ace Alzheimer Center Barcelona project (GR@ACE) is supported by Grifols SA, Fundación bancaria 'La Caixa', Ace Alzheimer Center Barcelona and CIBERNED. Ace Alzheimer Center Barcelona is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The FACEHBI study is supported by funds from Ace Alzheimer Center Barcelona, Grifols, Life Molecular Imaging, Araclon Biotech, Alkahest, Laboratorio de análisis Echevarne and IrsiCaixa. Authors acknowledge the support of the Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grants PID2021-122473OA-I00, PID2021-123462OB-I00 and PID2019-106625RB-I00. ISCIII, Acción Estratégica en Salud, integrated in the Spanish National R+D+I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER 'Una manera de hacer Europa') grants PI13/02434, PI16/01861, PI17/01474, PI19/00335, PI19/01240, PI19/01301, PI22/01403, PI22/00258 and the ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). The support of CIBERNED (ISCIII) under the grants CB06/05/2004 and CB18/05/00010. The support from the ADAPTED and MOPEAD projects, European Union/EFPIA Innovative Medicines Initiative Joint (grant numbers 115975 and 115985, respectively); from PREADAPT project, Joint Program for Neurodegenerative Diseases (JPND) grant AC19/00097; from HARPONE project, Agency for Innovation and Entrepreneurship (VLAIO) grant PR067/21 and Janssen. DESCARTES project is funded by German Research Foundation (DFG). Additionally, IdR is supported by the Instituto de Salud Carlos III (ISCIII) under grant FI20/00215. PGG is supported by CIBERNED employment plan (CNV-304-PRF-866). ACF received support from the ISCIII under the grant Sara Borrell (CD22/00125). JEC received support from National Institute of Health award P30AG066546., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

  • Puerta, Raquel
  • Pérez-Tur, Jordi
  • Bullido, María Jesús
  • Real, Luis Miguel
  • Mir, Pablo
  • Ruiz, Agustín
  • Alzheimer’s Disease Neuroimaging Initiative
27 páginas, 7 figuras, 3 tablas, Alzheimer's disease (AD) is a complex disease with a strong genetic component, yet many genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid endophenotypes measured in cerebrospinal fluid (CSF) and positron emission tomography (PET) as surrogates of amyloid pathology, which may provide insights into the underlying biology of the disease. We performed a meta-GWAS of CSF Aβ42 and PET measures combining six independent cohorts (n = 2,076). Given the opposite beta direction of Aβ phenotypes in CSF and PET measures, only genetic signals showing opposite directions were considered for analysis (n = 376,599). We explored the amyloidosis signature in the CSF proteome using SOMAscan proteomics (ACE cohort, n = 1,008), connected it with GWAS loci modulating amyloidosis and performed an enrichment analysis of overlapping hits. Finally, we compared our results with a large meta-analysis using publicly available datasets in CSF (n = 13,409) and PET (n = 13,116). After filtering the meta-GWAS, we observed genome-wide significance in the rs429358-APOE locus and annotated nine suggestive hits. We replicated the APOE loci using the large CSF-PET meta-GWAS, identifying multiple AD-associated genes including the novel GADL1 locus. Additionally, we found 1,387 FDR-significant SOMAscan proteins associated with CSF Aβ42 levels. The overlap among GWAS loci and proteins associated with amyloid burden was minimal (n = 35). The enrichment analysis revealed mechanisms connecting amyloidosis with the plasma membrane's anchored component, synapse physiology and mental disorders that were replicated in the large CSF-PET meta-analysis. Combining CSF and PET amyloid GWAS with CSF proteome analyses may effectively elucidate causative molecular mechanisms behind amyloid mobilization and AD physiopathology., The Genome Research @ Ace Alzheimer Center Barcelona project (GR@ACE) is supported by Grifols SA, Fundación bancaria ‘La Caixa’, Ace Alzheimer Center Barcelona and CIBERNED. Ace Alzheimer Center Barcelona is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The FACEHBI study is supported by funds from Ace Alzheimer Center Barcelona, Grifols, Life Molecular Imaging, Araclon Biotech, Alkahest, Laboratorio de análisis Echevarne and IrsiCaixa. Authors acknowledge the support of the Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grants PID2021-122473OA-I00, PID2021-123462OB-I00 and PID2019-106625RB-I00. ISCIII, Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER “Una manera de hacer Europa") grants PI13/02434, PI16/01861, PI17/01474, PI19/00335, PI19/01240, PI19/01301, PI22/01403, PI22/00258 and the ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). The support of CIBERNED (ISCIII) under the grants CB06/05/2004 and CB18/05/00010. The support from the ADAPTED and MOPEAD projects, European Union/EFPIA Innovative Medicines Initiative Joint (grant numbers 115975 and 115985, respectively); from PREADAPT project, Joint Program for Neurodegenerative Diseases (JPND) grant Nº AC19/00097; from HARPONE project, Agency for Innovation and Entrepreneurship (VLAIO) grant Nº PR067/21 and Janssen. DESCARTES project is funded by German Research Foundation (DFG). Additionally, AR is also supported by STAR Award. University of Texas System. Tx, United States, The South Texas ADRC. National Institute of Aging. National Institutes of Heath. USA. (P30AG066546) and the Keith M. Orme and Pat Vigeon Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases. IdR is supported by the Instituto de Salud Carlos III (ISCIII) under grant FI20/00215. PGG is supported by CIBERNED employment plan (CNV-304-PRF-866). ACF received support from the ISCIII under the grant Sara Borrell (CD22/00125). JEC received support from National Institute of Health award P30AG066546., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC

  • García-González, Pablo
  • Díaz Belloso, Rafael
  • Munoz-Delgado, Laura
  • Buiza Rueda, Dolores
  • Gómez-Garre, Pilar
  • Pérez-Tur, Jordi
  • Real, Luis M.
  • Bullido, María Jesús
  • Ruiz, Agustín
18 páginas, 2 figuras, Progressive supranuclear palsy (PSP) is a rare 4-repeat tauopathy that causes behavioural, movement and cognitive abnormalities. We genotyped all available clinical and histopathological PSP cases in Spain and Portugal (N = 522), and conducted the largest PSP GWAS of the Iberian population to date. Genetic burden analysis revealed reduced diagnostic specificity in clinically diagnosed atypical PSP cases-when applying the 2017 MDS criteria-compared to Richardson's syndrome cases. We independently replicated eight PSP risk variants in seven known loci (MAPT, MOBP, EIF2AK3, STX6, SLCO1A2, DUSP10 and APOE), and identified a novel locus in NFASC/CNTN2 (rs12744678 C: OR[95%CI] = 0.83[0.78-0.89]; p = 4.15·10-08) after meta-analysis with a newly available Dutch cohort and publicly available summary statistics (3,099 PSP; 11,482 controls). Enrichment analysis and protein expression profiling highlighted oligodendrocyte function and myelination as likely contributors to PSP pathogenesis. Our findings broaden the genetic landscape of PSP and suggest potential therapeutic avenues focused on modulating neuron-oligodendrocyte interactions., This work was funded by CIBERNED (Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas) 10th internal call for cooperative projects (Register number: 2019/09). Agustín Ruiz, Pascual Sanchez-Juan, Alberto Rábano, and Maria J. Bullido received funding from this convocatory. Pablo García-González received support by CIBERNED employment plan CNV-304-PRF-866. CIBERNED is integrated into ISCIII (Instituto de Salud Carlos III). Mercé Boada, Marta Marquié and Agustín Ruiz are also supported by national grants PI13/02434, PI16/01861, PI17/01474, PI19/01240, PI19/01301, PI19/00335 and PI22/011403, and CIBERNED grant 2019/08. The Genome Research @ Fundació ACE project (GR@ACE) is supported by Grifols SA, Fundación bancaria “La Caixa”, Fundació ACE, and CIBERNED. Acción Estratégica en Salud is integrated into the Spanish National R  +  D  +  I Plan and funded by ISCIII—Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de hacer Europa”). Agustín Ruiz is supported by ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). He is also supported by the STAR Award. University of Texas System. Tx, United States, The South Texas ADRC. National Institute of Aging. National Institutes of Health. USA. (P30AG066546), the Keith M. Orme and Pat Vigeon Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases (2024-2025) and Patricia Ruth Frederick Distinguished Chair for Precision Therapeutics in Alzheimer’s and Neurodegenerative Diseases (2025-2028). The genotyping service to generate GR@ACE and PSP/DEGESCO GWAS data was carried out at CEGEN-PRB3-ISCIII; it is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF”. Itziar de Rojas received support by a national grant from ISCIII FI20/00215. Amanda Cano acknowledges the support of the Spanish Ministry of Science, Innovation and Universities under the grant Juan de la Cierva (FJC2018-036012-I), the support of ISCIII under the grant Sara Borrell (CD22/00125), Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grant PID2021-122473OA-I00, and Fundación ADEY under the program “Proyectos de Investigación en Salud 2023”. Fondo de Investigacion en Salud (Instituto Carlos III) (PI17/00096) in the frame of the European Regional Development Fund (ERDF) and to Fundacio ́ la Marato ́ de TV3 (PI043296 and 202009-10). This work was supported by the Spanish Ministry of Science and Innovation (RTC2019-007150-1), the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI14/01823, PI16/01575, PI18/01898, PI19/01576, PI21/01875), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685, PY20_00896), and the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019). Pilar Gómez-Garre was supported by the “Nicolás Monardes” program (C-0048-2017) from Andalusian Regional Ministry of Health. Laura Muñoz-Delgado was supported by the “Río Hortega” program [CM21/00051] from the Instituto de Salud Carlos III (ISCIII-FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sven J. van der Lee was funded for this study by NWO (#733050512, PROMO-GENODE: a PROspective study of MOnoGEnic causes Of Dementia) a substantial donation by Edwin Bouw Fonds and Dioraphte. SvdL further received funding for the GeneMINDS consortium, which is powered by Health~Holland, Top Sector Life Sciences & Health. Sven J. van der Lee is a recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). More than 30 partners participate in ABOARD. ABOARD also receives funding from Edwin Bouw Fonds and Gieskes-Strijbisfonds. ABOARD also receives funding from de Hersenstichting, Edwin Bouw Fonds and Gieskes-Strijbisfonds. Array genotyping was performed in the context of EADB (European Alzheimer DNA biobank) funded by the JPco-fuND FP-829-029 (ZonMW projectnumber 733051061). This work has been supported by the Queen Sofia Foundation. Pascual Sánchez-Juan is supported by grants from ISCIII (PMP22/00022 and PI20/01011) and TED2021-131676B-100. Luis Miguel Real received support from “The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations” (GEHEP-012 study). Consejería de Salud de la Junta de Andalucía (grant number PI-0001/2017) and CIBERINFEC -Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas- Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación y Unión Europea (Spain) (NextGeneration EU) (grant number CB21/13/00118). Jose Luis Royo received support from Project 23.04.2021 from Santángela Foundation (Sevilla, Spain)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In vivo architectonic stability of fully de novo designed protein-only nanoparticles

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Tatkiewicz, Witold
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Álamo, Patricia|||0000-0003-0510-5701
  • Xu, Zhikun
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Cedano, Juan|||0000-0003-1380-8036
  • Daura i Ribera, Xavier|||0000-0001-9235-6730
  • Ratera Bastardas, Imma|||0000-0002-1464-9789
  • Veciana i Miró, Jaume|||0000-0003-1023-9923
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
The fully de novo design of protein building blocks for self-assembling as functional nanoparticles is a challenging task in emerging nanomedicines, which urgently demand novel, versatile, and biologically safe vehicles for imaging, drug delivery, and gene therapy. While the use of viruses and virus-like particles is limited by severe constraints, the generation of protein-only nanocarriers is progressively reachable by the engineering of protein-protein interactions, resulting in self-assembling functional building blocks. In particular, end-terminal cationic peptides drive the organization of structurally diverse protein species as regular nanosized oligomers, offering promise in the rational engineering of protein self-assembling. However, the in vivo stability of these constructs, being a critical issue for their medical applicability, needs to be assessed. We have explored here if the cross-molecular contacts between protein monomers, generated by end-terminal cationic peptides and oligohistidine tags, are stable enough for the resulting nanoparticles to overcome biological barriers in assembled form. The analyses of renal clearance and biodistribution of several tagged modular proteins reveal long-term architectonic stability, allowing systemic circulation and tissue targeting in form of nanoparticulate material. This observation fully supports the value of the engineered of protein building blocks addressed to the biofabrication of smart, robust, and multifunctional nanoparticles with medical applicability that mimic structure and functional capabilities of viral capsids.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model

  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Di Nicolantonio, Federica
  • Pavón Ribas, Miguel Ángel
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Trias Folch, Manuel
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Bardelli, Alberto
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Mangues, Ramon|||0000-0003-2661-9525
Although all KRas (protein that in humans is encoded by the KRas gene) point mutants are considered to have a similar prognostic capacity, their transformation and tumorigenic capacities vary widely. We compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model. Following subcutaneous preconditioning, recombinant clones of the SW48 CRC cell line [Kras wild-type (Kras WT)] expressing the KRas G12V or KRas G13D allele were microinjected in the mouse cecum. The percentage of animals developing lymph node metastasis was higher in KRas G12V than in KRas G13D mice. Microscopic, macroscopic, and visible lymphatic foci were 1.5- to 3.0-fold larger in KRas G12V than in KRas G13D mice (P < 0.05). In the lung, only microfoci were developed in both groups. KRas G12V primary tumors had lower apoptosis (7.0 ± 1.2 vs. 7.4 ± 1.0 per field, P = 0.02), higher tumor budding at the invasion front (1.2 ± 0.2 vs. 0.6 ± 0.1, P = 0.04), and a higher percentage of C-X-C chemokine receptor type 4 (CXCR4)-overexpressing intravasated tumor emboli (49.8 ± 9.4% vs. 12.8 ± 4.4%, P < 0.001) than KRas G13D tumors. KRas G12V primary tumors showed Akt activation, and β5 integrin, vascular endothelial growth factor A (VEGFA), and Serpine-1 overexpression, whereas KRas G13D tumors showed integrin β1 and angiopoietin 2 (Angpt2) overexpression. The increased cell survival, invasion, intravasation, and specific molecular regulation observed in KRas G12V tumors is consistent with the higher aggressiveness observed in patients with CRC expressing this oncogene.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting low-density lipoprotein receptors with protein-only nanoparticles

  • Xu, Zhikun
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Álamo, Patricia|||0000-0003-0510-5701
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
Low-density lipoprotein receptors (LDLR) are appealing cell surface targets in drug delivery, as they are expressed in the blood-brain barrier (BBB) endothelium and are able to mediate transcytosis of functionalized drugs for molecular therapies of the central nervous system (CNS). On the other hand, brain-targeted drug delivery is currently limited, among others, by the poor availability of biocompatible vehicles, as most of the nanoparticles under development as drug carriers pose severe toxicity issues. In this context, protein nanoparticles offer functional versatility, easy and cost-effective bioproduction, and full biocompatibility. In this study, we have designed and characterized several chimerical proteins containing different LDLR ligands, regarding their ability to bind and internalize target cells and to self-organize as viral mimetic nanoparticles of about 18 nm in diameter. While the self-assembling of LDLR-binding proteins as nanoparticles positively influences cell penetration in vitro, the nanoparticulate architecture might be not favoring BBB crossing in vivo. These findings are discussed in the context of the use of nanostructured materials as vehicles for the systemic treatment of CNS diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Formulating tumor-homing peptides as regular nanoparticles enhances receptor-mediated cell penetrability

  • Xu, Zhikun
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Roldán, Mónica
  • Mangues, Ramon|||0000-0003-2661-9525
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Homing peptides are exploited in nanomedicine to functionalize either free drugs or nanostructured materials used as drug carriers. However, the influence of multivalent versus monovalent peptide presentation on the interaction with the receptor and on the consequent intracellular delivery of the associated cargo remains poorly explored. By using a tumor-homing peptide (T22) with regulatable self-assembling properties we have investigated here if its display in a either a monomeric form or as multimeric, self-assembled protein nanoparticles might determine the efficacy of receptor-mediated penetrability into target cells. This has been monitored by using a fluorescent cargo protein (iRFP), which when fused to the homing peptide acts as convenient reporter. The results indicate that the nanoparticulate protein versions are significantly more efficient in mediating receptor-dependent uptake than their unassembled counterparts. These finding stresses an additional benefit of nanostructured materials based on repetitive building blocks, regarding the multivalent presentation of cell ligands that facilitate cell penetration in drug delivery applications.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Towards Protein-Based Viral Mimetics for Cancer Therapies

  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Vázquez, Esther|||0000-0003-1052-0424
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
High resistance and recurrence rates, along with elevated drug clearance, compel the use of maximum tolerated drug doses in cancer therapy, resulting in high-grade toxicities and limited clinical applicability. Promoting active drug accumulation in tumor tissues would minimize such issues and improve therapeutic outcomes. A new class of therapeutic drugs suitable for the task has emerged based on the concept of virus-mimetic nanocarriers, or 'artificial viruses.' Among the spectrum of materials under exploration in nanocarrier research, proteins offer unparalleled structural and functional versatility for designing viruslike molecular vehicles. By exhibiting 'smart' functions and biomimetic traits, protein-based nanocarriers will be a step ahead of the conventional drug-protein conjugates already in the clinics in ensuring efficient delivery of passenger antitumor drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models

  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Pavón Ribas, Miguel Ángel
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Trias, Manuel
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Céspedes, María Virtudes|||0000-0003-2956-5833
Mouse colorectal cancer (CRC) models generated by orthotopic microinjection of human CRC cell lines reproduce the pattern of lymphatic, haematological and transcoelomic spread but generate low metastatic efficiency. Our aim was to develop a new strategy that could increase the metastatic efficiency of these models. We used subcutaneous implantation of the human CRC cell lines HCT116 or SW48 prior to their orthotopic microinjection in the cecum of nude mice (SC+ORT). This subcutaneous preconditioning significantly enhanced metastatic dissemination. In the HCT116 model it increased the number and size of metastatic foci in lymph nodes, lung, liver and peritoneum, whereas, in the SW48 model, it induced a shift from nonmetastatic to metastatic. In both models the number of apoptotic bodies in the primary tumour in the SC+ORT group was significantly reduced compared with that in the direct orthotopic injection (ORT) group. Moreover, in HCT116 tumours the number of keratin-positive tumour buddings and single epithelial cells increased at the invasion front in SC+ORT mice. In the SW48 tumour model, we observed a trend towards a higher number of tumour buds and single cells in the SC+ORT group but this did not reach statistical significance. At a molecular level, the enhanced metastatic efficiency observed in the HCT116 SC+ORT model was associated with an increase in AKT activation, VEGF-A overexpression and downregulation of β1 integrin in primary tumour tissue, whereas, in SW48 SC+ORT mice, the level of expression of these proteins remained unchanged. In summary, subcutaneous preconditioning increased the metastatic dissemination of both orthotopic CRC models by increasing tumour cell survival and invasion at the tumour invasion front. This approach could be useful to simultaneously study the mechanisms of metastases and to evaluate anti-metastatic drugs against CRC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome Wide Meta-Analysis identifies common genetic signatures shared by heart function and Alzheimer's disease

  • Sáez, María Eugenia|||0000-0001-9299-2534
  • González-Pérez, A.
  • Hernández-Olasagarre, B.
  • Beà, Aida|||0000-0002-9733-4618
  • Moreno-Grau, Sonia
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Monté-Rubio, Gemma C.|||0000-0002-3532-2224
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Valero, S.
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
  • Sanchís, D.
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Echocardiography has become an indispensable tool for the study of heart performance, improving the monitoring of individuals with cardiac diseases. Diverse genetic factors associated with echocardiographic measures have been previously reported. The impact of several apoptotic genes in heart development identified in experimental models prompted us to assess their potential association with human cardiac function. This study aimed at investigating the possible association of variants of apoptotic genes with echocardiographic traits and to identify new genetic markers associated with cardiac function. Genome wide data from different studies were obtained from public repositories. After quality control and imputation, a meta-analysis of individual association study results was performed. Our results confirmed the role of caspases and other apoptosis related genes with cardiac phenotypes. Moreover, enrichment analysis showed an over-representation of genes, including some apoptotic regulators, associated with Alzheimer's disease. We further explored this unexpected observation which was confirmed by genetic correlation analyses. Our findings show the association of apoptotic gene variants with echocardiographic indicators of heart function and reveal a novel potential genetic link between echocardiographic measures in healthy populations and cognitive decline later on in life. These findings may have important implications for preventative strategies combating Alzheimer's disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks, The GR@ACE project

  • Moreno-Grau, Sonia
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Hernández, Isabel|||0000-0001-8119-393X
  • Quintela, Inés|||0000-0002-0239-7975
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Hernández-Olasagarre, Begoña
  • Madrid, Laura|||0000-0001-5851-3341
  • González-Perez, Antonio
  • Maroñas, Olalla
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Mauleón, Ana|||0000-0002-4218-2127
  • Vargas, Liliana|||0000-0001-5685-5903
  • Lafuente, Asunción
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Rodríguez-Gómez, Octavio
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Espinosa, Ana|||0000-0001-7399-3267
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Cañabate, Pilar
  • Moreno, Mariola
  • Preckler, Silvia
  • Ruiz, Susana
  • Aguilera, Núria
  • Pineda, Juan Antonio
  • Macías, Juan|||0000-0002-4778-790X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Benaque, Alba
  • Boada, Mercè|||0000-0003-2617-3009
  • Buendía, Mar
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Corbatón-Anchuelo, Arturo
  • Diego, S.
  • Gailhajenet, A.
  • García González, P.
  • Guitart, Maria|||0000-0003-2957-7404
  • Ibarria, Marta
  • Macias, J.
  • Martín, E.
  • Martínez, M. T.
  • Marquié, Marta|||0000-0002-0660-0950
  • Monté-Rubio, Gemma C.|||0000-0002-3532-2224
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Pancho, A.
  • Pelejà, E.
  • Real, L. M.
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Ruiz-Janer, Sabina|||0000-0002-8073-9504
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Serrano-Rios, M.
  • Tárraga, L.
  • Valero, S.
  • Adarmes-Gómez, A.D.|||0000-0002-1337-9289
  • Álvarez, I.
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Amer Ferrer, Guillermo
  • Antequera, M.
  • Antúnez, Carmen
  • Baquero, Miquel|||0000-0002-6861-1831
  • Bernal, M.
  • Blesa, Rafael|||0000-0003-4026-2884
  • Buiza-Rueda, Dolores|||0000-0002-3504-9299
  • Bullido, María J.|||0000-0002-6477-1117
  • Burguera, J. A.
  • Calero, Miguel|||0000-0001-5366-3324
  • Carrillo, F.
  • Carrión-Claro, M.
  • Casajeros, M. J.
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Cruz-Gamero, J. M.
  • Pancorbo, Marian M. de
  • del Ser, Teodoro|||0000-0001-9806-7083
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Fortea, Juan|||0000-0002-1340-638X
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Frank García, Ana
  • García-Alberca, J. M.
  • García-Madrona, Sebastián
  • García-Ribas, Guillermo
  • Gómez-Garre, Pilar|||0000-0002-0437-6182
  • Hevilla, S.
  • Jesús Maestre, Silvia|||0000-0002-1874-4628
  • Espinosa, Labrador
  • Lage, Carmen|||0000-0003-1703-121X
  • Legaz, A.
  • Lleó, Alberto|||0000-0002-2568-5478
  • López de Munáin, A.
  • López-García, S.
  • Macías-García, Daniel|||0000-0002-4822-1529
  • Manzanares, S.
  • Marín, M.
  • Marín Muñoz, Juan|||0000-0002-7512-6121
  • Marín, T.
  • Martín Montes, Angel|||0000-0002-1694-786X
  • Martínez, Benjamín|||0000-0001-9879-7748
  • Martínez, C.
  • Martínez, V.
  • Martínez-Lage Álvarez, P.
  • Medina, Miguel|||0000-0002-7016-5340
  • Mendioroz, Maite|||0000-0002-4179-5781
  • Menéndez González, Manuel
  • Mir, Pablo|||0000-0003-1656-302X
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Pastor, A. B.
  • Pástor, P.
  • Pérez-Tur, Jordi|||0000-0002-9111-1712
  • Periñán-Tocino, T.
  • Piñol-Ripoll, Gerard
  • Rábano, Alberto|||0000-0001-9320-6566
  • Real de Asua, D.
  • Rodrigo, S.
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Royo, J. L.
  • Sanchez del Valle Díaz, R.
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Sastre, I.
  • Vicente, M. P.
  • Vivancos, Liliana
  • Ávila, J.
Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta-analyzed with additional genome-wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A C6orf10 / LOC101929163 locus is associated with age of onset in C9orf72 carriers

  • Zhang, Ming
  • Ferrari, Raffaele
  • Tartaglia, Maria Carmela
  • Keith, Julia
  • Surace, Ezequiel I.
  • Wolf, Uri
  • Sato, Christine
  • Grinberg, Mark
  • Liang, Yan
  • Xi, Zhengrui
  • Dupont, Kyle
  • McGoldrick, Philip
  • Weichert, Anna
  • McKeever, Paul M.
  • Schneider, Raphael
  • McCorkindale, Michael D.
  • Manzoni, Claudia|||0000-0001-5367-4023
  • Rademakers, Rosa
  • Graff-Radford, Neill R.
  • Dickson, Dennis W.|||0000-0001-7189-7917
  • Parisi, Joseph E.
  • Boeve, Bradley
  • Petersen, Ronald C.
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Seeley, William W.
  • van Swieten, John C.
  • van Rooij, Jeroen
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Van der Zee, Julie|||0000-0003-4381-8040
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Le Ber, Isabelle|||0000-0002-2508-5181
  • Van Deerlin, Vivianna|||0000-0002-7400-9097
  • Suh, EunRan
  • Rohrer, Jonathan D.
  • Mead, Simon|||0000-0002-4326-1468
  • Graff, Caroline|||0000-0002-9949-2951
  • Öijerstedt, Linn
  • Pickering-Brown, S.|||0000-0003-1561-6054
  • Rollinson, Sara|||0000-0002-0921-4318
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Brooks, William S.
  • Dobson-Stone, Carol
  • Halliday, Glenda M.
  • Hodges, John R.
  • Piguet, Olivier
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Benussi, Luisa|||0000-0003-2836-8141
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Bruni, Amalia|||0000-0003-3471-3343
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Scarpini, Elio|||0000-0002-6395-2119
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rubino, Elisa|||0000-0002-7553-7553
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Lleó, Alberto|||0000-0002-2568-5478
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Hernández, Isabel|||0000-0001-8119-393X
  • Pastor, Pau|||0000-0002-7493-8777
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Borroni, Barbara|||0000-0001-9340-9814
  • Pasquier, Florence|||0000-0001-9880-9788
  • Deramecourt, Vincent
  • Lebouvier, Thibaud
  • Perneczky, Robert|||0000-0003-1981-7435
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Grafman, Jordan
  • Huey, Edward D.
  • Mayeux, Richard|||0000-0001-6519-9696
  • Nalls, Michael A..
  • Hernandez, Dena
  • Singleton, Andrew B.|||0000-0001-5606-700X
  • Momeni, Parastoo
  • Zeng, Zhen
  • Hardy, John|||0000-0002-3122-0423
  • Robertson, Janice
  • Zinman, Lorne
  • Rogaeva, Ekaterina
Discovery of disease age-of-onset modifiers is important for clinical trials and drug design. Zhang et al. perform a genome-wide analysis of epigenetic functional polymorphisms and identify an association between the C6orf10/LOC101929163 locus and age of FTD/ALS onset. The risk allele may be associated with a pro-inflammatory state in the brain. The GC-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis and frontotemporal dementia. The high phenotypic heterogeneity of C9orf72 patients includes a wide range in age of onset, modifiers of which are largely unknown. Age of onset could be influenced by environmental and genetic factors both of which may trigger DNA methylation changes at CpG sites. We tested the hypothesis that age of onset in C9orf72 patients is associated with some common single nucleotide polymorphisms causing a gain or loss of CpG sites and thus resulting in DNA methylation alterations. Combined analyses of epigenetic and genetic data have the advantage of detecting functional variants with reduced likelihood of false negative results due to excessive correction for multiple testing in genome-wide association studies. First, we estimated the association between age of onset in C9orf72 patients (n = 46) and the DNA methylation levels at all 7603 CpG sites available on the 450 k BeadChip that are mapped to common single nucleotide polymorphisms. This was followed by a genetic association study of the discovery (n = 144) and replication (n = 187) C9orf72 cohorts. We found that age of onset was reproducibly associated with polymorphisms within a 124.7 kb linkage disequilibrium block tagged by top-significant variation, rs9357140, and containing two overlapping genes (LOC101929163 and C6orf10). A meta-analysis of all 331 C9orf72 carriers revealed that every A-allele of rs9357140 reduced hazard by 30% (P = 0.0002); and the median age of onset in AA-carriers was 6 years later than GG-carriers. In addition, we investigated a cohort of C9orf72 negative patients (n = 2634) affected by frontotemporal dementia and/or amyotrophic lateral sclerosis; and also found that the AA-genotype of rs9357140 was associated with a later age of onset (adjusted P = 0.007 for recessive model). Phenotype analyses detected significant association only in the largest subgroup of patients with frontotemporal dementia (n = 2142, adjusted P = 0.01 for recessive model). Gene expression studies of frontal cortex tissues from 25 autopsy cases affected by amyotrophic lateral sclerosis revealed that the G-allele of rs9357140 is associated with increased brain expression of LOC101929163 (a non-coding RNA) and HLA-DRB1 (involved in initiating immune responses), while the A-allele is associated with their reduced expression. Our findings suggest that carriers of the rs9357140 GG-genotype (linked to an earlier age of onset) might be more prone to be in a pro-inflammatory state (e.g. by microglia) than AA-carriers. Further, investigating the functional links within the C6orf10 / LOC101929163 / HLA-DRB1 pathway will be critical to better define age-dependent pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long runs of homozygosity are associated with Alzheimer's disease

  • Moreno-Grau, Sonia
  • Fernández, Maria Victoria|||0000-0002-9669-5147
  • De Rojas, Itziar|||0000-0002-2148-381X
  • García-González, Pablo|||0000-0003-0125-5403
  • Hernández, Isabel|||0000-0001-8119-393X
  • Farias, Fabiana|||0000-0002-5215-7304
  • Budde, John P.|||0000-0001-7778-7276
  • Quintela, Inés|||0000-0002-0239-7975
  • Madrid, Laura|||0000-0001-5851-3341
  • González-Pérez, Antonio
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Maroñas, Olalla
  • Pineda, Juan Antonio
  • Macías, Juan|||0000-0002-4778-790X
  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Benaque, Alba
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Bullido, María J.|||0000-0002-6477-1117
  • García-Ribas, Guillermo
  • Pastor, Pau|||0000-0002-7493-8777
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Piñol-Ripoll, Gerard
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Royo, José Luis
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Mir, Pablo|||0000-0003-1656-302X
  • Calero, Miguel|||0000-0001-5366-3324
  • Medina, Miguel|||0000-0002-7016-5340
  • Rábano, Alberto|||0000-0001-9320-6566
  • Ávila, Jesús
  • Antúnez, Carmen
  • Real, Luis M.|||0000-0003-4932-7429
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [ β (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10 -5 ; β (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

  • Costa, Beatrice
  • Manzoni, Claudia|||0000-0001-5367-4023
  • Bernal-Quiros, Manuel
  • Kia, Demis A.
  • Aguilar Barberà, Miquel
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Anfossi, Maria
  • Bagnoli, Silvia
  • Benussi, Luisa|||0000-0003-2836-8141
  • Bernardi, Livia
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Blackburn, Daniel
  • Boada, Mercè|||0000-0003-2617-3009
  • Borroni, Barbara|||0000-0001-9340-9814
  • Bowns, Lucy
  • Bråthen, Geir|||0000-0003-3224-7983
  • Bruni, Amalia|||0000-0003-3471-3343
  • Chiang, Huei-Hsin
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Colville, Shuna
  • Conidi, Maria E.
  • Cope, Tom E.
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Cupidi, Chiara
  • Di Battista, Maria Elena
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Durante, Elisabetta
  • Flisar, Dušan
  • Frangipane, Francesca
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Gallo, Maura
  • Gallucci, Maurizio
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Graff, Caroline|||0000-0002-9949-2951
  • Grafman, Jordan H.
  • Grossman, Murray|||0000-0002-7447-6218
  • Hardy, John|||0000-0002-3122-0423
  • Hernández, Isabel|||0000-0001-8119-393X
  • Holloway, Guy J. T.
  • Huey, Edward D.
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Karydas, Anna
  • Khoshnood, Behzad
  • Kramberger, Milica G.
  • Kristiansen, Mark
  • Lewis, Patrick|||0000-0003-4537-0489
  • Lleó, Alberto|||0000-0002-2568-5478
  • Madhan, Gaganjit K.
  • Maletta, Raffaele|||0000-0002-0758-1835
  • Maver, Ales
  • Menéndez González, Manuel
  • Milan, Graziella
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Mol, Merel O.|||0000-0003-2533-2530
  • Momeni, Parastoo
  • Moreno-Grau, Sonia
  • Morris, Chris M.|||0000-0002-3749-0993
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Nilsson, Christer
  • Novelli, Valeria
  • Öijerstedt, Linn
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Pal, Suvankar
  • Panchbhaya, Yasmin
  • Pastor, Pau|||0000-0002-7493-8777
  • Peterlin, Borut|||0000-0001-7824-4978
  • Piaceri, Irene|||0000-0001-6787-2223
  • Pickering-Brown, S.|||0000-0003-1561-6054
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Puca, Annibale A.
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rendina, Antonella|||0000-0001-5331-2807
  • Richardson, Anna M. T.
  • Rogaeva, Ekaterina
  • Rogelj, Boris|||0000-0003-3898-1943
  • Rollinson, Sara|||0000-0002-0921-4318
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Rossmeier, Carola
  • Rowe, James B.
  • Rubino, Elisa|||0000-0002-7553-7553
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Sando, Sigrid B.
  • Santillo, Alexander F.
  • Saxon, Jennifer
  • Scarpini, Elio|||0000-0002-6395-2119
  • Serpente, Maria
  • Smirne, Nicoletta
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Suh, EunRan
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Thompson, Jennifer C.
  • Trojanowski, John Q.|||0000-0002-9239-8794
  • Van Deerlin, Vivianna|||0000-0002-7400-9097
  • Van der Zee, Julie|||0000-0003-4381-8040
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • van Rooij, Jeroen
  • van Swieten, John C.
  • Veronesi, Arianna
  • Vitale, Emilia|||0000-0003-4651-3875
  • Waldö, Maria L.
  • Woodward, Cathy
  • Yokoyama, Jennifer S.|||0000-0001-7274-2634
  • Escott-Price, Valentina|||0000-0003-1784-5483
  • Polke, James M.
  • Ferrari, Raffaele
We sought to characterize C9orf72 expansions in relation to genetic ancestry and age at onset (AAO) and to use these measures to discriminate the behavioral from the language variant syndrome in a large pan-European cohort of frontotemporal lobar degeneration (FTLD) cases. We evaluated expansions frequency in the entire cohort (n = 1,396; behavioral variant frontotemporal dementia [bvFTD] [n = 800], primary progressive aphasia [PPA] [n = 495], and FTLD-motor neuron disease [MND] [n = 101]). We then focused on the bvFTD and PPA cases and tested for association between expansion status, syndromes, genetic ancestry, and AAO applying statistical tests comprising Fisher exact tests, analysis of variance with Tukey post hoc tests, and logistic and nonlinear mixed-effects model regressions. We found C9orf72 pathogenic expansions in 4% of all cases (56/1,396). Expansion carriers differently distributed across syndromes: 12/101 FTLD-MND (11.9%), 40/800 bvFTD (5%), and 4/495 PPA (0.8%). While addressing population substructure through principal components analysis (PCA), we defined 2 patients groups with Central/Northern (n = 873) and Southern European (n = 523) ancestry. The proportion of expansion carriers was significantly higher in bvFTD compared to PPA (5% vs 0.8% [ p = 2.17 × 10 -5 ; odds ratio (OR) 6.4; confidence interval (CI) 2.31-24.99]), as well as in individuals with Central/Northern European compared to Southern European ancestry (4.4% vs 1.8% [ p = 1.1 × 10 -2 ; OR 2.5; CI 1.17-5.99]). Pathogenic expansions and Central/Northern European ancestry independently and inversely correlated with AAO. Our prediction model (based on expansions status, genetic ancestry, and AAO) predicted a diagnosis of bvFTD with 64% accuracy. Our results indicate correlation between pathogenic C9orf72 expansions, AAO, PCA-based Central/Northern European ancestry, and a diagnosis of bvFTD, implying complex genetic risk architectures differently underpinning the behavioral and language variant syndromes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Marquié, Marta|||0000-0002-0660-0950
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Hernández, Isabel|||0000-0001-8119-393X
  • Mauleón, Ana|||0000-0002-4218-2127
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Tartari, Juan P.
  • Vargas, Liliana|||0000-0001-5685-5903
  • Espinosa, Ana|||0000-0001-7399-3267
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Valero, Sergi|||0000-0002-6599-948X
Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer's disease (AD) and other dementia types in patients diagnosed with Mild Cognitive Impairment (MCI). Our aim was to determine profiles based on the prominent NPS in MCI patients and to explore the predictive value of these profiles on conversion to specific types of dementia. A total of 2137 MCI patients monitored in a memory clinic were included in the study. Four NPS profiles emerged (classes), which were defined by preeminent symptoms: Irritability, Apathy, Anxiety/Depression and Asymptomatic. Irritability and Apathy were predictors of conversion to dementia (HR = 1.43 and 1.56, respectively). Anxiety/depression class showed no risk effect of conversion when compared to Asymptomatic class. Irritability class appeared as the most discriminant neuropsychiatric condition to identify non-AD converters (i.e., frontotemporal dementia, vascular dementia, Parkinson's disease and dementia with Lewy Bodies). The findings revealed that consistent subgroups of MCI patients could be identified among comorbid basal NPS. The preeminent NPS showed to behave differentially on conversion to dementia, beyond AD. Therefore, NPS should be used as early diagnosis facilitators, and should also guide clinicians to detect patients with different illness trajectories in the progression of MCI.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Tesi, Niccolo|||0000-0002-1413-5091
  • Grenier-Boley, Benjamin
  • Andrade, Victor|||0000-0003-0682-269X
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Stringa, Najada|||0000-0001-6350-452X
  • Zettergren, Anna|||0000-0002-7182-8417
  • Hernández, Isabel|||0000-0001-8119-393X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Antúnez, Carmen
  • Antonell, Anna|||0000-0002-3286-8459
  • Tankard, Rick M.|||0000-0002-8847-9401
  • Bis, Joshua C.|||0000-0002-3409-1110
  • Sims, Rebecca|||0000-0002-3885-1199
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Perez, Antonio
  • Calero, Miguel|||0000-0001-5366-3324
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Macías, Juan|||0000-0002-4778-790X
  • Blesa, Rafael|||0000-0003-4026-2884
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Frank García, Ana
  • Royo, Jose Luís
  • Moreno, Fermin|||0000-0001-5200-3164
  • Huerto Vilas, Raquel
  • Baquero, Miquel|||0000-0002-6861-1831
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Lage, Carmen|||0000-0003-1703-121X
  • García-Madrona, Sebastián
  • García-González, Pablo|||0000-0003-0125-5403
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Valero, Sergi|||0000-0002-6599-948X
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Ullgren, Abbe
  • Naj, Adam C.|||0000-0002-9621-2942
  • Lemstra, Afina W.|||0000-0002-8933-3260
  • Benaque, Alba
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Benussi, Alberto|||0000-0002-8703-6940
  • Rábano, Alberto|||0000-0001-9320-6566
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Squassina, Alessio|||0000-0001-7415-7607
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Arias Pastor, Alfonso
  • Kok, Almar A. L.
  • Meggy, Alun
  • Pastor, Ana Belén|||0000-0001-9637-4688
  • Espinosa, Ana|||0000-0001-7399-3267
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Martín Montes, Angel|||0000-0002-1694-786X
  • Sanabria, Ángela|||0000-0002-7501-9895
  • DeStefano, Anita L.|||0000-0002-9335-2819
  • Schneider, Anja|||0000-0001-9540-8700
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Kinhult Ståhlbom, Anne
  • Tybjærg-Hansen, Anne
  • Hartmann, Annette M.
  • Spottke, Annika
  • Corbatón-Anchuelo, Arturo
  • Rongve, Arvid|||0000-0002-0476-4134
  • Borroni, Barbara|||0000-0001-9340-9814
  • Arosio, Beatrice|||0000-0002-0615-3580
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Nordestgaard, Børge G.|||0000-0002-1954-7220
  • Kunkle, Brian W.
  • Charbonnier, Camille|||0000-0003-1172-0196
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Masullo, Carlo|||0000-0001-7798-3410
  • Martínez Rodríguez, Carmen
  • Muñoz-Fernandez, Carmen
  • Dufouil, Carole|||0000-0003-2442-4476
  • Graff, Caroline|||0000-0002-9949-2951
  • Ferreira, Catarina B.
  • Chillotti, Caterina
  • Reynolds, Chandra A.|||0000-0001-6502-7173
  • Fenoglio, Chiara|||0000-0001-6332-4721
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Clark, Christopher|||0000-0001-7210-7702
  • Pisanu, Claudia|||0000-0002-9151-4319
  • Satizabal, Claudia L.|||0000-0002-1115-4430
  • Holmes, Clive
  • Buiza-Rueda, Dolores|||0000-0002-3504-9299
  • Aarsland, Dag|||0000-0001-6314-216X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Wallon, David|||0000-0002-2634-7198
  • Seripa, Davide|||0000-0001-7331-0470
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Dardiotis, Efthimios|||0000-0003-2957-641X
  • Düzel, Emrah
  • Scarpini, Elio|||0000-0002-6395-2119
  • Conti, Elisa
  • Rubino, Elisa|||0000-0002-7553-7553
  • Gelpi, Ellen|||0000-0003-2948-4187
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Duron, Emmanuelle
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Ferri, Evelyn
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Küçükali, Fahri
  • Pasquier, Florence|||0000-0001-9880-9788
  • Sánchez García, Florentino
  • Mangialasche, Francesca
  • Jessen, Frank
  • Nicolas, Gael|||0000-0001-9391-7800
  • Selbæk, Geir|||0000-0001-6511-8219
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Chene, Geneviève|||0000-0002-8368-6460
  • Hadjigeorgiou, Georgios
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Giaccone, Giorgio|||0000-0002-4803-0802
  • Grande, Giulia
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Papenberg, Goran
  • Hampel, Harald
  • Bailly, Henri
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Karlsson, Ida K.
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Appollonio, Ildebrando
  • Giegling, Ina
  • Skoog, Ingmar
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rosas Allende, Irene
  • Hort, Jakub|||0000-0002-1080-3726
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Lehtisalo, Jenni
  • Wiltfang, Jens
  • Thomassen, Jesper Qvist|||0000-0003-3484-9531
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Haines, Jonathan L.|||0000-0002-4351-4728
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Fortea, Juan|||0000-0002-1340-638X
  • Popp, Julius|||0000-0002-0068-0312
  • Deckert, Jürgen|||0000-0003-1008-4650
  • Buerger, Katharina
  • Morgan, Kevin|||0000-0002-8217-2396
  • Fließbach, Klaus
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Kilander, Lena
  • Weinhold, Leonie
  • Farrer, Lindsay A.|||0000-0001-5533-4225
  • Wang, Li-San
  • Kleineidam, Luca
  • Farotti, Lucia
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Tremolizzo, Lucio|||0000-0003-0473-6560
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Benussi, Luisa|||0000-0003-2836-8141
  • Froelich, Lutz|||0000-0003-1494-0813
  • Ikram, M. Arfan|||0000-0003-0372-8585
  • Deniz Naranjo, M. Cándida
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Löwenmark, Malin
  • Hulsman, Marc|||0000-0002-9889-3606
  • Spallazzi, Marco|||0000-0002-8091-2063
  • Pericak-Vance, Margaret A.|||0000-0001-7283-8804
  • Esiri, Margaret
  • Bernal Sánchez-Arjona, María
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Martínez-Larrad, María Teresa
  • Arcaro, Marina|||0000-0002-3821-0682
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Fernández-Fuertes, Marta
  • Dichgans, Martin|||0000-0002-0654-387X
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Herrmann, Martin J.|||0000-0001-9970-2122
  • Scherer, Martin
  • Vyhnalek, Martin
  • Kosmidis, Mary H.
  • Yannakoulia, Mary
  • Schmid, Matthias
  • Ewers, Michael|||0000-0001-5231-1714
  • Heneka, Michael|||0000-0003-4996-1630
  • Wagner, Michael
  • Scamosci, Michela
  • Kivipelto, Miia
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Zulaica, Miren
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Fornage, Myriam|||0000-0003-0677-8158
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • van Schoor, Natasja M.
  • Seidu, Nazib M.
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Scarmeas, Nikolaos|||0000-0001-6453-8908
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Goldhardt, Oliver
  • Hanon, Olivier|||0000-0002-4697-122X
  • Peters, Oliver|||0000-0003-0568-2998
  • Skrobot, Olivia Anna
  • Quenez, Olivier|||0000-0002-8273-8505
  • Lerch, Ondrej
  • Bossù, Paola|||0000-0002-1432-0078
  • Caffarra, Paolo
  • Dionigi Rossi, Paolo
  • Sakka, Paraskevi
  • Hoffmann, Per|||0000-0002-6573-983X
  • Holmans, Peter|||0000-0003-0870-9412
  • Fischer, Peter
  • Riederer, Peter
  • Yang, Qiong|||0000-0002-3658-1375
  • Marshall, Rachel
  • Kalaria, Rajesh N.
  • Mayeux, Richard|||0000-0001-6519-9696
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Cecchetti, Roberta
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Frikke-Schmidt, Ruth|||0000-0003-4084-5027
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Hägg, Sara|||0000-0002-2452-1500
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Helisalmi, Seppo
  • Botne Sando, Sigrid
  • Kern, Silke
  • Archetti, Silvana
  • Boschi, Silvia|||0000-0003-1610-1917
  • Fostinelli, Silvia
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Mendoza, Silvia
  • Mead, Simon|||0000-0002-4326-1468
  • Ciccone, Simona
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • del Ser, Teodoro|||0000-0001-9806-7083
  • Lebouvier, Thibaud
  • Polak, Thomas
  • Ngandu, Tiia
  • Grimmer, Timo
  • Bessi, Valentina|||0000-0002-6176-3584
  • Escott-Price, Valentina|||0000-0003-1784-5483
  • Giedraitis, Vilmantas|||0000-0003-3423-2021
  • Deramecourt, Vincent
  • Maier, Wolfgang
  • Jian, Xueqiu
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Kehoe, Patrick|||0000-0002-7542-1139
  • García-Ribas, Guillermo
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Pastor, Pau|||0000-0002-7493-8777
  • Pérez-Tur, Jordi|||0000-0002-9111-1712
  • Piñol-Ripoll, Gerard
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Bullido, María J.|||0000-0002-6477-1117
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Lleó, Alberto|||0000-0002-2568-5478
  • Real, Luis M.|||0000-0003-4932-7429
  • Mir, Pablo|||0000-0003-1656-302X
  • Medina, Miguel|||0000-0002-7016-5340
  • Scheltens, Philip|||0000-0002-1046-6408
  • Holstege, Henne|||0000-0002-7688-3087
  • Marquié, Marta|||0000-0002-0660-0950
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Schellenberg, Gerard D.
  • Williams, Julie|||0000-0002-4069-0259
  • Seshadri, Sudha|||0000-0001-6135-2622
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Mather, Karen A.|||0000-0003-4143-8941
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Serrano-Ríos, Manuel
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Blennow, Kaj|||0000-0002-1890-4193
  • Huisman, Martijn A.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Boada, Mercè|||0000-0003-2617-3009
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease. Known genetic loci account for only a fraction of the genetic contribution to Alzheimer's disease. Here, the authors have performed a large genome-wide meta-analysis comprising 409,435 individuals to discover 6 new loci and demonstrate the efficacy of an Alzheimer's disease polygenic risk score.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Marquié, Marta|||0000-0002-0660-0950
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Hernández, Isabel|||0000-0001-8119-393X
  • Mauleón, Ana|||0000-0002-4218-2127
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Tartari, Juan P.
  • Vargas, Liliana|||0000-0001-5685-5903
  • López-Cuevas, Rogelio
  • Bojaryn, Urszula
  • Espinosa, Ana|||0000-0001-7399-3267
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Valero, Sergi|||0000-0002-6599-948X
Introduction: Mild cognitive impairment is often associated with affective and other neuropsychiatric symptoms (NPS). This co-occurrence might have a relevant impact on disease progression, from MCI to dementia. Objective: The aim of this study was to explore the trajectories of cognitive decline in an MCI sample from a memory clinic, taking into consideration a perspective of isolated cognitive functions and based on NPS clusters, accounting for the different comorbid symptoms collected at their baseline visit. Methods: A total of 2,137 MCI patients were monitored over a 2.4-year period. Four clusters of NPS (i.e., Irritability, Apathy, Anxiety/Depression and Asymptomatic) were used to run linear mixed models to explore the interaction of cluster with time on cognitive trajectories using a comprehensive neuropsychological battery (NBACE) administered at baseline and at the three subsequent follow-ups. Results: A significant interaction between cluster and time in cognitive decline was found when verbal learning and cued-recall were explored (p = 0.002 for both memory functions). For verbal learning, the Irritability cluster had the largest effect size (0.69), whereas the Asymptomatic cluster showed the smallest effect size (0.22). For cued-recall, the Irritability cluster had the largest effect size among groups (0.64), and Anxiety/Depression had the smallest effect size (0.21). Conclusions: In MCI patients, the Irritability and Apathy NPS clusters shared similar patterns of worsening in memory functioning, which could point to these NPS as risk factors of a faster cognitive decline, acting as early prognostic markers and helping in the diagnostic process.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Author Correction, Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Tesi, Niccolo|||0000-0002-1413-5091
  • Grenier-Boley, Benjamin
  • Andrade, Victor|||0000-0003-0682-269X
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Stringa, Najada|||0000-0001-6350-452X
  • Zettergren, Anna|||0000-0002-7182-8417
  • Hernández, Isabel|||0000-0001-8119-393X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Antúnez, Carmen
  • Antonell, Anna|||0000-0002-3286-8459
  • Tankard, Rick M.|||0000-0002-8847-9401
  • Bis, Joshua C.|||0000-0002-3409-1110
  • Sims, Rebecca|||0000-0002-3885-1199
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Perez, Antonio
  • Calero, Miguel|||0000-0001-5366-3324
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Macías, Juan|||0000-0002-4778-790X
  • Blesa, Rafael|||0000-0003-4026-2884
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Frank García, Ana
  • Royo, Jose Luís
  • Moreno, Fermin|||0000-0001-5200-3164
  • Huerto Vilas, Raquel
  • Baquero, Miquel|||0000-0002-6861-1831
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Lage, Carmen|||0000-0003-1703-121X
  • García-Madrona, Sebastián
  • García-González, Pablo|||0000-0003-0125-5403
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Valero, Sergi|||0000-0002-6599-948X
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Ullgren, Abbe
  • Naj, Adam C.|||0000-0002-9621-2942
  • Lemstra, Afina W.|||0000-0002-8933-3260
  • Benaque, Alba
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Benussi, Alberto|||0000-0002-8703-6940
  • Rábano, Alberto|||0000-0001-9320-6566
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Squassina, Alessio|||0000-0001-7415-7607
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Arias Pastor, Alfonso
  • Kok, Almar A. L.
  • Meggy, Alun
  • Pastor, Ana Belén|||0000-0001-9637-4688
  • Espinosa, Ana|||0000-0001-7399-3267
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Martín Montes, Angel|||0000-0002-1694-786X
  • Sanabria, Ángela|||0000-0002-7501-9895
  • DeStefano, Anita L.|||0000-0002-9335-2819
  • Schneider, Anja|||0000-0001-9540-8700
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Kinhult Ståhlbom, Anne
  • Tybjærg-Hansen, Anne
  • Hartmann, Annette M.
  • Spottke, Annika
  • Corbatón-Anchuelo, Arturo
  • Rongve, Arvid|||0000-0002-0476-4134
  • Borroni, Barbara|||0000-0001-9340-9814
  • Arosio, Beatrice|||0000-0002-0615-3580
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Nordestgaard, Børge G.|||0000-0002-1954-7220
  • Kunkle, Brian W.
  • Charbonnier, Camille|||0000-0003-1172-0196
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Masullo, Carlo|||0000-0001-7798-3410
  • Martínez Rodríguez, Carmen
  • Muñoz-Fernandez, Carmen
  • Dufouil, Carole|||0000-0003-2442-4476
  • Graff, Caroline|||0000-0002-9949-2951
  • Ferreira, Catarina B.
  • Chillotti, Caterina
  • Reynolds, Chandra A.|||0000-0001-6502-7173
  • Fenoglio, Chiara|||0000-0001-6332-4721
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Clark, Christopher|||0000-0001-7210-7702
  • Pisanu, Claudia|||0000-0002-9151-4319
  • Satizabal, Claudia L.|||0000-0002-1115-4430
  • Holmes, Clive
  • Buiza-Rueda, Dolores|||0000-0002-3504-9299
  • Aarsland, Dag|||0000-0001-6314-216X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Wallon, David|||0000-0002-2634-7198
  • Seripa, Davide|||0000-0001-7331-0470
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Dardiotis, Efthimios|||0000-0003-2957-641X
  • Düzel, Emrah
  • Scarpini, Elio|||0000-0002-6395-2119
  • Conti, Elisa
  • Rubino, Elisa|||0000-0002-7553-7553
  • Gelpi, Ellen|||0000-0003-2948-4187
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Duron, Emmanuelle
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Ferri, Evelyn
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Küçükali, Fahri
  • Pasquier, Florence|||0000-0001-9880-9788
  • Sánchez García, Florentino
  • Mangialasche, Francesca
  • Jessen, Frank
  • Nicolas, Gael|||0000-0001-9391-7800
  • Selbæk, Geir|||0000-0001-6511-8219
  • Ortega, Gemma
  • Chene, Geneviève|||0000-0002-8368-6460
  • Hadjigeorgiou, Georgios
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Giaccone, Giorgio|||0000-0002-4803-0802
  • Grande, Giulia
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Papenberg, Goran
  • Hampel, Harald
  • Bailly, Henri
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Karlsson, Ida K.
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Appollonio, Ildebrando
  • Giegling, Ina
  • Skoog, Ingmar
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rosas Allende, Irene
  • Hort, Jakub|||0000-0002-1080-3726
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Lehtisalo, Jenni
  • Wiltfang, Jens
  • Thomassen, Jesper Qvist|||0000-0003-3484-9531
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Haines, Jonathan L.|||0000-0002-4351-4728
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Fortea, Juan|||0000-0002-1340-638X
  • Popp, Julius|||0000-0002-0068-0312
  • Deckert, Jürgen|||0000-0003-1008-4650
  • Buerger, Katharina
  • Morgan, Kevin|||0000-0002-8217-2396
  • Fließbach, Klaus
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Kilander, Lena
  • Weinhold, Leonie
  • Farrer, Lindsay A.|||0000-0001-5533-4225
  • Wang, Li-San
  • Kleineidam, Luca
  • Farotti, Lucia
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Tremolizzo, Lucio|||0000-0003-0473-6560
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Benussi, Luisa|||0000-0003-2836-8141
  • Froelich, Lutz|||0000-0003-1494-0813
  • Ikram, M. Arfan|||0000-0003-0372-8585
  • Deniz Naranjo, M. Cándida
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Löwenmark, Malin
  • Hulsman, Marc|||0000-0002-9889-3606
  • Spallazzi, Marco|||0000-0002-8091-2063
  • Pericak-Vance, Margaret A.|||0000-0001-7283-8804
  • Esiri, Margaret
  • Bernal Sánchez-Arjona, María
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Martínez-Larrad, María Teresa
  • Arcaro, Marina|||0000-0002-3821-0682
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Fernández-Fuertes, Marta
  • Dichgans, Martin|||0000-0002-0654-387X
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Herrmann, Martin J.|||0000-0001-9970-2122
  • Scherer, Martin
  • Vyhnalek, Martin
  • Kosmidis, Mary H.
  • Yannakoulia, Mary
  • Schmid, Matthias
  • Ewers, Michael|||0000-0001-5231-1714
  • Heneka, Michael|||0000-0003-4996-1630
  • Wagner, Michael
  • Scamosci, Michela
  • Kivipelto, Miia
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Zulaica, Miren
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Fornage, Myriam|||0000-0003-0677-8158
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • van Schoor, Natasja M.
  • Seidu, Nazib M.
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Scarmeas, Nikolaos|||0000-0001-6453-8908
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Goldhardt, Oliver
  • Hanon, Olivier|||0000-0002-4697-122X
  • Peters, Oliver|||0000-0003-0568-2998
  • Skrobot, Olivia Anna
  • Quenez, Olivier|||0000-0002-8273-8505
  • Lerch, Ondrej
  • Bossù, Paola|||0000-0002-1432-0078
  • Caffarra, Paolo
  • Dionigi Rossi, Paolo
  • Sakka, Paraskevi
  • Mecocci, Patrizia|||0000-0003-0729-5246
  • Hoffmann, Per|||0000-0002-6573-983X
  • Holmans, Peter|||0000-0003-0870-9412
  • Fischer, Peter
  • Riederer, Peter
  • Yang, Qiong|||0000-0002-3658-1375
  • Marshall, Rachel
  • Kalaria, Rajesh N.
  • Mayeux, Richard|||0000-0001-6519-9696
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Cecchetti, Roberta
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Frikke-Schmidt, Ruth|||0000-0003-4084-5027
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Hägg, Sara|||0000-0002-2452-1500
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Helisalmi, Seppo
  • Botne Sando, Sigrid
  • Kern, Silke
  • Archetti, Silvana
  • Boschi, Silvia|||0000-0003-1610-1917
  • Fostinelli, Silvia
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Mendoza, Silvia
  • Mead, Simon|||0000-0002-4326-1468
  • Ciccone, Simona
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • del Ser, Teodoro|||0000-0001-9806-7083
  • Lebouvier, Thibaud
  • Polak, Thomas
  • Ngandu, Tiia
  • Grimmer, Timo
  • Bessi, Valentina|||0000-0002-6176-3584
  • Escott-Price, Valentina|||0000-0003-1784-5483
  • Giedraitis, Vilmantas|||0000-0003-3423-2021
  • Deramecourt, Vincent
  • Maier, Wolfgang
  • Jian, Xueqiu
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Kehoe, Patrick|||0000-0002-7542-1139
  • García-Ribas, Guillermo
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Pastor, Pau|||0000-0002-7493-8777
  • Pérez-Tur, Jordi|||0000-0002-9111-1712
  • Piñol-Ripoll, Gerard
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Bullido, María J.|||0000-0002-6477-1117
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Lleó, Alberto|||0000-0002-2568-5478
  • Real, Luis M.|||0000-0003-4932-7429
  • Mir, Pablo|||0000-0003-1656-302X
  • Medina, Miguel|||0000-0002-7016-5340
  • Scheltens, Philip|||0000-0002-1046-6408
  • Holstege, Henne|||0000-0002-7688-3087
  • Marquié, Marta|||0000-0002-0660-0950
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Schellenberg, Gerard D.
  • Williams, Julie|||0000-0002-4069-0259
  • Seshadri, Sudha|||0000-0001-6135-2622
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Mather, Karen A.|||0000-0003-4143-8941
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Serrano-Ríos, Manuel
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Blennow, Kaj|||0000-0002-1890-4193
  • Huisman, Martijn A.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Boada, Mercè|||0000-0003-2617-3009
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

  • Jansen, Iris E.|||0000-0003-1901-8131
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Gomez-Fonseca, Duber
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Grenier-Boley, Benjamin
  • Zettergren, Anna|||0000-0002-7182-8417
  • Mishra, Aniket|||0000-0002-8141-1543
  • Ali, Muhammad|||0000-0002-1399-6631
  • Andrade, Victor|||0000-0003-0682-269X
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Kleineidam, Luca
  • Küçükali, Fahri
  • Sung, Ju Sung
  • Tesí, Niccolo
  • Vromen, Ellen|||0000-0001-7774-5500
  • Wightman, Douglas P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Athanasiu, Lavinia
  • Bahrami, Shahram
  • Bailly, Henri
  • Belbin, Olivia|||0000-0002-6109-6371
  • Bergh, Sverre|||0000-0001-9593-2967
  • Bertram, Lars|||0000-0002-0108-124X
  • Biessels, Geert Jan|||0000-0001-6862-2496
  • Blennow, Kaj|||0000-0002-1890-4193
  • Blesa, Rafael|||0000-0003-4026-2884
  • Boada, Mercè|||0000-0003-2617-3009
  • Boland, Anne|||0000-0001-8789-5676
  • Buerger, K.
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Chene, Geneviève|||0000-0002-8368-6460
  • Claassen, Jurgen|||0000-0002-1778-8151
  • Debette, Stéphanie|||0000-0001-8675-7968
  • Deleuze, Jean-Francois
  • De Deyn, Peter Paul|||0000-0002-2228-2964
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Dufouil, Carole|||0000-0003-2442-4476
  • Duron, Emmanuelle
  • Düzel, Emrah
  • Fladby, Tormod|||0000-0002-9984-9797
  • Fortea, Juan|||0000-0002-1340-638X
  • Froelich, Lutz|||0000-0003-1494-0813
  • García-González, Pablo|||0000-0003-0125-5403
  • Garcia-Martinez, María
  • Giegling, Ina
  • Goldhardt, Oliver
  • Gobom, Johan|||0000-0001-6193-6193
  • Grimmer, Timo
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Hampel, Harald
  • Hanon, Olivier|||0000-0002-4697-122X
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Helisalmi, Seppo
  • Heneka, Michael|||0000-0003-4996-1630
  • Hernández, Isabel|||0000-0001-8119-393X
  • Herukka, Sanna-Kaisa|||0000-0003-3308-8662
  • Holstege, Henne|||0000-0002-7688-3087
  • Jarholm, Jonas
  • Kern, Silke
  • Knapskog, Anne-Brita
  • Koivisto, A.M.
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • Lage, Carmen|||0000-0003-1703-121X
  • Laske, Christoph
  • Leinonen, Ville|||0000-0002-4282-4687
  • Lewczuk, Piotr|||0000-0002-8101-6535
  • Lleó, Alberto|||0000-0002-2568-5478
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • López-Garcia, Sara
  • Maier, Wolfgang
  • Marquié, Marta|||0000-0002-0660-0950
  • Mol, Merel O.|||0000-0003-2533-2530
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Moreno, Fermin|||0000-0001-5200-3164
  • Moreno-Grau, Sonia
  • Nicolas, Gael|||0000-0001-9391-7800
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Pålhaugen, Lene
  • Papma, Janne M.
  • Pasquier, Florence|||0000-0001-9880-9788
  • Perneczky, Robert|||0000-0003-1981-7435
  • Peters, Oliver|||0000-0003-0568-2998
  • Pijnenburg, Yolande A.L.
  • Popp, Julius|||0000-0002-0068-0312
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Pozueta, Ana
  • Priller, Josef|||0000-0001-7596-0979
  • Puerta, Raquel|||0000-0002-1191-5893
  • Quintela, Inés|||0000-0002-0239-7975
  • Ramakers, Inez
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Scheltens, Philip|||0000-0002-1046-6408
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Schmid, Matthias
  • Schneider, Anja|||0000-0001-9540-8700
  • Selbæk, Geir|||0000-0001-6511-8219
  • Selnes, Per
  • Shadrin, Alexey
  • Skoog, Ingmar
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Teipel, Stefan
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • van Swieten, John C.
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Visser, Pieter Jelle|||0000-0001-8008-9727
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Waern, Margda|||0000-0002-8330-6915
  • Wagner, Michael
  • Wiltfang, Jens W.
  • Wittens, Mandy M.J.
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Zulaica, Miren
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Bjerke, Maria
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Jessen, Frank
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Pastor, Pau|||0000-0002-7493-8777
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Characteristics of subjective cognitive decline associated with amyloid positivity

  • Janssen, Olin|||0000-0002-8341-0958
  • Jansen, Willemijn J.
  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • Boada, Mercè|||0000-0003-2617-3009
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Gabryelewicz, Tomasz
  • Fladby, Tormod|||0000-0002-9984-9797
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Villeneuve, Sylvia
  • Hort, Jakub|||0000-0002-1080-3726
  • Epelbaum, Stéphane
  • Lleó, Alberto|||0000-0002-2568-5478
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Landau, Susan
  • Popp, Julius|||0000-0002-0068-0312
  • Wallin, Anders|||0000-0001-9506-0513
  • Scheltens, Philip|||0000-0002-1046-6408
  • Rikkert, Marcel Olde|||0000-0003-1397-1677
  • Snyder, Peter J.|||0000-0003-0555-4654
  • Rowe, Chris
  • Chételat, G.|||0000-0002-4889-7932
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Marquié, Marta|||0000-0002-0660-0950
  • Chipi, Elena
  • Wolfsgruber, Steffen
  • Heneka, Michael|||0000-0003-4996-1630
  • Boecker, Henning|||0000-0003-2346-0598
  • Peters, Oliver|||0000-0003-0568-2998
  • Jarholm, Jonas
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Pichet Binette, Alexa|||0000-0001-5218-3337
  • Poirier, Judes
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Cerman, Jiri
  • Dubois, Bruno
  • Teichmann, Marc
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Ebenau, Jarith
  • Pocnet, Cornelia
  • Eckerström, Marie
  • Thompson, Louisa
  • Villemagne, Victor
  • Buckley, Rachel|||0000-0002-5356-5537
  • Burnham, Samantha
  • Delarue, Marion
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Wallin, Åsa K.
  • Ramakers, Inez
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Hampel, Harald
  • Spiru, Luiza
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Ossenkoppele, Rik
  • Verhey, Frans
  • Jessen, Frank
  • Visser, Pieter Jelle|||0000-0001-8008-9727
Introduction: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods: In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Results: Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Discussion: Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort

  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • García-González, Pablo|||0000-0003-0125-5403
  • Valero, Sergi|||0000-0002-6599-948X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Hernández, Isabel|||0000-0001-8119-393X
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Vargas, Liliana|||0000-0001-5685-5903
  • Tartari, Juan Pablo
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Bojaryn, Urszula
  • Narvaiza, Leire
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Pytel, Vanesa
  • Cano, Amanda|||0000-0001-9567-4283
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Background: Clinical diagnosis of Alzheimer's disease (AD) increasingly incorporates CSF biomarkers. However, due to the intrinsic variability of the immunodetection techniques used to measure these biomarkers, establishing in-house cutoffs defining the positivity/negativity of CSF biomarkers is recommended. However, the cutoffs currently published are usually reported by using cross-sectional datasets, not providing evidence about its intrinsic prognostic value when applied to real-world memory clinic cases. Methods: We quantified CSF Aβ1-42, Aβ1-40, t-Tau, and p181Tau with standard INNOTEST® ELISA and Lumipulse G® chemiluminescence enzyme immunoassay (CLEIA) performed on the automated Lumipulse G600II. Determination of cutoffs included patients clinically diagnosed with probable Alzheimer's disease (AD, n = 37) and subjective cognitive decline subjects (SCD, n = 45), cognitively stable for 3 years and with no evidence of brain amyloidosis in 18F-Florbetaben-labeled positron emission tomography (FBB-PET). To compare both methods, a subset of samples for Aβ1-42 (n = 519), t-Tau (n = 399), p181Tau (n = 77), and Aβ1-40 (n = 44) was analyzed. Kappa agreement of single biomarkers and Aβ1-42/Aβ1-40 was evaluated in an independent group of mild cognitive impairment (MCI) and dementia patients (n = 68). Next, established cutoffs were applied to a large real-world cohort of MCI subjects with follow-up data available (n = 647). Results: Cutoff values of Aβ1-42 and t-Tau were higher for CLEIA than for ELISA and similar for p181Tau. Spearman coefficients ranged between 0.81 for Aβ1-40 and 0.96 for p181TAU. Passing-Bablok analysis showed a systematic and proportional difference for all biomarkers but only systematic for Aβ1-40. Bland-Altman analysis showed an average difference between methods in favor of CLEIA. Kappa agreement for single biomarkers was good but lower for the Aβ1-42/Aβ1-40 ratio. Using the calculated cutoffs, we were able to stratify MCI subjects into four AT(N) categories. Kaplan-Meier analyses of AT(N) categories demonstrated gradual and differential dementia conversion rates (p = 9.815). Multivariate Cox proportional hazard models corroborated these findings, demonstrating that the proposed AT(N) classifier has prognostic value. AT(N) categories are only modestly influenced by other known factors associated with disease progression. Conclusions: We established CLEIA and ELISA internal cutoffs to discriminate AD patients from amyloid-negative SCD individuals. The results obtained by both methods are not interchangeable but show good agreement. CLEIA is a good and faster alternative to manual ELISA for providing AT(N) classification of our patients. AT(N) categories have an impact on disease progression. AT(N) classifiers increase the certainty of the MCI prognosis, which can be instrumental in managing real-world MCI subjects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors

  • Mira, Alessia
  • Morello, Virginia
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Perera, Timothy
  • Comoglio, Paolo M.
  • Mangues, Ramon|||0000-0003-2661-9525
  • Michieli, Paolo
The role of paracrine Hepatocyte Growth Factor (HGF) in the resistance to angiogenesis inhibitors (AIs) is hidden in xenograft models because mouse HGF fails to fully activate human MET. To uncover it, we compared the efficacy of AIs in wild-type and human HGF knock-in SCID mice bearing orthotopic human colorectal tumors. Species-specific HGF/MET signaling dramatically impaired the response to anti-angiogenic agents and boosted metastatic dissemination. In cell-based assays mimicking the consequences of anti-angiogenic therapy, colorectal cancer cells were completely resistant to hypoxia but extremely sensitive to nutrient deprivation. Starvation-induced apoptosis could be prevented by HGF, which promoted GLUT1-mediated glucose uptake, sustained glycolysis and activated autophagy. Pharmacological inhibition of GLUT1 in the presence of glucose killed tumor cells as effectively as glucose deprivation, and this effect was antagonized by HGF. Concomitant targeting of GLUT1 and HGF potently suppressed growth and dissemination of AI-resistant human tumors in human HGF knock-in SCID mice without exacerbating tumor hypoxia. These data suggest that stroma-derived HGF protects CRC cells against glucose starvation-induced apoptosis, promoting resistance to both AIs and anti-glycolytic agents. Combined inhibition of glucose metabolism and HGF/MET signaling ('anti-METabolic therapy') may represent a more effective CRC treatment compared to utterly blocking tumor blood supply.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients

  • Pavón, Miguel Ángel|||0000-0003-3677-5329
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Téllez Gabriel, Marta|||0000-0002-0895-2677
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Virós, David
  • López, Montserrat
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Quer, Miquel|||0000-0003-2563-6729
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Mangues, Ramon|||0000-0003-2661-9525
High SERPINE1 expression is a common event in head and neck squamous cell carcinoma (HNSCC); however, whether it plays a role in determining clinical outcome remains still unknown. We studied SERPINE1 as a prognostic marker in two HNSCC patient cohorts. In a retrospective study (n = 80), high expression of SERPINE1 was associated with poor progression-free (p = 0.022) and cancer-specific (p = 0.040) survival. In a prospective study (n = 190), high SERPINE1 expression was associated with poor local recurrence-free (p = 0.022), progression-free (p = 0.002) and cancer-specific (p = 0.006) survival. SERPINE1 expression was identified as an independent risk factor for progression-free survival in patients treated with chemo-radiotherapy or radiotherapy (p = 0.043). In both patient cohorts, high SERPINE1 expression increased the risk of metastasis spread (p = 0.045; p = 0.029). The association between SERPINE1 expression and survival was confirmed using the HNSCC cohort included in The Cancer Genome Atlas project (n = 507). Once again, patients showing high expression had a poorer survival (p < 0.001). SERPINE1 over-expression in HNSCC cells reduced cell proliferation and enhanced migration. It also protected cells from cisplatin-induced apoptosis, which was accompanied by PI3K/AKT pathway activation. Downregulation of SERPINE1 expression had the opposite effect. We propose SERPINE1 expression as a prognostic marker that could be used to stratify HNSCC patients according to their risk of recurrence.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease

  • Wang, Lihua
  • Nykänen, Niko-Petteri
  • Western, Daniel|||0000-0003-3725-9553
  • Gorijala, Priyanka
  • Timsina, Jigyasha
  • Li, Fuhai
  • Wang, Zhaohua
  • Ali, Muhammad|||0000-0002-1399-6631
  • Yang, Chengran
  • Liu, Menghan
  • Brock, William
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Aguilar, Miquel
  • Pastor, Pau|||0000-0002-7493-8777
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Puerta, Raquel|||0000-0002-1191-5893
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Rutledge, Jarod
  • Oh, Hamilton
  • Greicius, Michael. D.
  • Le Guen, Yann Le
  • Perrin, Richard J.
  • Wyss-Coray, Tony
  • Jefferson, Angela
  • Hohman, Timothy J.
  • Graff-Radford, Neill
  • Mori, Hiroshi
  • Goate, Alison|||0000-0002-0576-2472
  • Levin, Johannes|||0000-0001-5092-4306
  • Sung, Yun Ju
  • Cruchaga, Carlos|||0000-0002-0276-2899
Triggering receptor expressed on myeloid cells 2 (TREM2) plays a critical role in microglial activation, survival, and apoptosis, as well as in Alzheimer's disease (AD) pathogenesis. We previously reported the MS4A locus as a key modulator for soluble TREM2 (sTREM2) in cerebrospinal fluid (CSF). To identify additional novel genetic modifiers of sTREM2, we performed the largest genome-wide association study (GWAS) and identified four loci for CSF sTREM2 in 3,350 individuals of European ancestry. Through multi-ethnic fine mapping, we identified two independent missense variants (p.M178V in MS4A4A and p.A112T in MS4A6A) that drive the association in MS4A locus and showed an epistatic effect for sTREM2 levels and AD risk. The novel TREM2 locus on chr 6 contains two rare missense variants (rs75932628 p.R47H, P=7.16×10; rs142232675 p.D87N, P=2.71×10) associated with sTREM2 and AD risk. The third novel locus in the TGFBR2 and RBMS3 gene region (rs73823326, P=3.86×10) included a regulatory variant with a microglia-specific chromatin loop for the promoter of TGFBR2. Using cell-based assays we demonstrate that overexpression and knock-down of TGFBR2, but not RBMS3, leads to significant changes of sTREM2. The last novel locus is located on the APOE region (rs11666329, P=2.52×10), but we demonstrated that this signal was independent of APOE genotype. This signal colocalized with cis-eQTL of NECTIN2 in the brain cortex and cis-pQTL of NECTIN2 in CSF. Overexpression of NECTIN2 led to an increase of sTREM2 supporting the genetic findings. To our knowledge, this is the largest study to date aimed at identifying genetic modifiers of CSF sTREM2. This study provided novel insights into the MS4A and TREM2 loci, two well-known AD risk genes, and identified TGFBR2 and NECTIN2 as additional modulators involved in TREM2 biology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Huntingtin CAG repeats in neuropathologically confirmed tauopathies, Novel insights

  • Pérez-Oliveira, Sergio|||0000-0002-3292-0501
  • Castilla-Silgado, Juan|||0000-0002-6266-8247
  • Painous, Cèlia|||0000-0002-7027-3093
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Blázquez Estrada, Marta|||0000-0003-3348-9992
  • Corte, Daniela
  • Tomás-Zapico, Cristina|||0000-0001-7823-0410
  • Compta, Yaroslau|||0000-0001-6443-0104
  • Muñoz García, José Esteban|||0000-0002-0986-1291
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Balasa, Mircea|||0000-0002-1795-4228
  • Aragonès, Gemma
  • García-González, Pablo|||0000-0003-0125-5403
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Pastor, Pau|||0000-0002-7493-8777
  • Casa-Fages, Beatriz de la|||0000-0003-0486-3308
  • Rábano, Alberto|||0000-0001-9320-6566
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Molina-Porcel, L.
  • Alvarez, Victoria|||0000-0002-1916-2523
Previous studies have suggested a relationship between the number of CAG triplet repeats in the HTT gene and neurodegenerative diseases not related to Huntington's disease (HD). This study seeks to investigate whether the number of CAG repeats of HTT is associated with the risk of developing certain tauopathies and its influence as a modulator of the clinical and neuropathological phenotype. Additionally, it aims to evaluate the potential of polyglutamine staining as a neuropathological screening. We genotyped the HTT gene CAG repeat number and APOE-ℰ isoforms in a cohort of patients with neuropathological diagnoses of tauopathies (n=588), including 34 corticobasal degeneration (CBD), 98 progressive supranuclear palsy (PSP) and 456 Alzheimer's disease (AD). Furthermore, we genotyped a control group of 1070 patients, of whom 44 were neuropathologic controls. We identified significant differences in the number of patients with pathological HTT expansions in the CBD group (2.7%) and PSP group (3.2%) compared to control subjects (0.2%). A significant increase in the size of the HTT CAG repeats was found in the AD compared to the control group, influenced by the presence of the Apoliprotein E (APOE)-ℰ4 isoform. Post-mortem assessments uncovered tauopathy pathology with positive polyglutamine aggregates, with a slight predominance in the neostriatum for PSP and CBD cases and somewhat greater limbic involvement in the AD case. Our results indicated a link between HTT CAG repeat expansion with other non-HD pathology, suggesting they could share common neurodegenerative pathways. These findings support that genetic or histological screening for HTT repeat expansions should be considered in tauopathies.